We are live on ! Find out more
ANAB icon

AnaptysBio

136 hedge funds and large institutions have $601M invested in AnaptysBio in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 36 increasing their positions, 45 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

176% more call options, than puts

Call options by funds: $4.6M | Put options by funds: $1.67M

41% more capital invested

Capital invested by funds: $425M → $601M (+$175M)

21% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 19

3% more funds holding

Funds holding: 132136 (+4)

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

4.48% less ownership

Funds ownership: 106.66%102.18% (-4.5%)

20% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 45

Holders
136
Holders Change
+4
Holders Change %
+3.03%
% of All Funds
2.41%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
23
Increased
36
Reduced
45
Closed
19
Calls
$4.6M
Puts
$1.67M
Net Calls
+$2.94M
Net Calls Change
+$4.19M
Name Holding Trade Value Shares
Change
Change in
Stake
UBS AM
76
UBS AM
Illinois
$363K
Deutsche Bank
77
Deutsche Bank
Germany
$362K +$137K +5,652 +50%
Jane Street
78
Jane Street
New York
$350K -$71.8K -2,958 -15%
EGM
79
Engineers Gate Manager
New York
$333K +$376K +15,490 New
Group One Trading
80
Group One Trading
Illinois
$323K +$187K +7,706 +105%
QI
81
QS Investors
New York
$320K +$362K +14,900 New
CM
82
Caption Management
Oklahoma
$305K -$193K -7,943 -36%
GCP
83
GSA Capital Partners
United Kingdom
$294K -$298K -12,270 -47%
BFM
84
Boothbay Fund Management
New York
$291K +$329K +13,542 New
Manulife (Manufacturers Life Insurance)
85
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$289K +$3.86K +159 +1%
PMAM
86
Penn Mutual Asset Management
Pennsylvania
$278K +$314K +12,911 New
MAM
87
Martingale Asset Management
Massachusetts
$276K -$117K -4,802 -27%
VEA
88
Virtus ETF Advisers
New York
$263K -$106K -4,381 -26%
Rafferty Asset Management
89
Rafferty Asset Management
New York
$249K -$433K -17,835 -61%
MIM
90
MetLife Investment Management
New Jersey
$242K
State Board of Administration of Florida Retirement System
91
State Board of Administration of Florida Retirement System
Florida
$239K
JG
92
Jefferies Group
New York
$235K -$134K -5,529 -34%
Bank of America
93
Bank of America
North Carolina
$227K -$146K -6,028 -36%
Los Angeles Capital Management
94
Los Angeles Capital Management
California
$223K -$283K -11,650 -53%
IBT
95
International Biotechnology Trust
United Kingdom
$215K
MLICM
96
Metropolitan Life Insurance Company (MetLife)
New York
$175K
Barclays
97
Barclays
United Kingdom
$158K -$303K -12,461 -63%
Citigroup
98
Citigroup
New York
$152K +$94.2K +3,881 +121%
Simplex Trading
99
Simplex Trading
Illinois
$144K +$163K +6,722 New
WT
100
Whittier Trust
California
$135K

ANAB Hedge Fund Activity: Q4 2020 in Review

136 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in AnaptysBio (ANAB) for Q4 2020, worth a combined $601M — up 41% from $425M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new ANAB positions and 19 closed out — a net gain of 4 holders — while 36 added to existing stakes and 45 trimmed.

The largest buyer was Perceptive Advisors, opening a new position worth an estimated $29M. The largest seller was Frazier Management, cutting an estimated $34.4M.

  • 136 institutional investors held AnaptysBio (ANAB) as of Q4 2020, up from 132 in Q3 2020.
  • Funds reported $601M of AnaptysBio stock for Q4 2020, up 41% quarter-over-quarter.
  • 23 funds opened new AnaptysBio positions in Q4 2020 and 19 closed out, a net change of +4 holders.
  • The largest AnaptysBio buyer in Q4 2020 was Perceptive Advisors, an estimated $29M added.
  • The largest AnaptysBio seller in Q4 2020 was Frazier Management, an estimated $34.4M sold.

Based on aggregated 13F filings for Q4 2020.